Skip to main
GOVX
GOVX logo

Geovax Labs (GOVX) Stock Forecast & Price Target

Geovax Labs (GOVX) Analyst Ratings

Based on 9 analyst ratings
Strong Buy
Strong Buy 78%
Buy 22%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Geovax Labs Inc. is positioned favorably due to its advanced pipeline, which includes a next-generation COVID-19 vaccine and various immunotherapy programs aimed at both infectious diseases and solid tumors, underscoring its innovative approach in the biotechnology sector. The company’s commitment to vaccine accessibility, particularly in endemic regions, aligns with governmental support aimed at accelerating vaccine development, which may enhance potential funding and partnership opportunities. Additionally, the expansion of the biodefense industry and Geovax's diversified vaccine supply chain reinforces its strategic importance in strengthening global health security and resilience against future outbreaks.

Bears say

Geovax Labs Inc faces significant challenges that contribute to a negative outlook on its stock, primarily due to the high cost of its preferred COVID-19 vaccine, which may hinder widespread vaccination efforts and exacerbate global access inequalities. Additionally, production capacity limitations and reliance on a single supplier for vaccines increase the risk of supply chain disruptions, especially as demand from African health agencies far exceeds expected availability. These factors, coupled with ongoing logistical and political challenges in vaccine distribution, underscore the inadequacy of the global response to the pandemic and highlight the urgent need for alternative solutions.

Geovax Labs (GOVX) has been analyzed by 9 analysts, with a consensus rating of Strong Buy. 78% of analysts recommend a Strong Buy, 22% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Geovax Labs and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Geovax Labs (GOVX) Forecast

Analysts have given Geovax Labs (GOVX) a Strong Buy based on their latest research and market trends.

According to 9 analysts, Geovax Labs (GOVX) has a Strong Buy consensus rating as of Jul 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Geovax Labs (GOVX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.